Search Results 651-660 of 13355 for Birth Control Palette
Females of child-bearing potential must be non-lactating, must have a negative pregnancy test at Screening, and must agree to continue using contraception ...
The objective of the study is to assess the efficacy and safety of home use of a Control-to-Range (CTR) closed-loop (CL) system. Participation eligibility.
... contraceptive guidance during the treatment ... Note: As of amendment 06, contraception is no longer required for male participants. ... Subjects who use inhaled ...
* Male subjects and female subjects of childbearing potential (FOCBP) agree to use highly effective contraception measures from the time of first dose of ...
Abstinent or willing to use adequate contraception from Screening through the week 24 visit. Males (as assigned at birth) must fulfill the following criteria:.
... contraception throughout the treatment period and for 6 months after discontinuing study treatment. ... Chronic graft versus host disease (GVHD) or on ...
All sexually active female subjects of childbearing potential must agree to use a protocol recommended method of contraception during heterosexual ...
Chemotherapy is often used to prepare for a bone marrow transplant. Immune system disorders. Lower doses of chemotherapy drugs can help control an overactive ...
PD-L1 positive. 4. ECOG Performance Status ≤ 1 5. Adequate organ function 6. Willing to use highly effective method of birth control. Phase 1 Key Exclusion ...
Assigned female sex at birth. Willing to participate in a 30-minute virtual interview. Exclusion Criteria: Previous or current diagnosis of endometrial ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.